Skip to content

Traditional Korean Diet and Metabolic Disorder

Effects of Traditional Korean Diet on Metabolic Disorder : An Epigenomic Approach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005340
Enrollment
50
Registered
2020-08-24
Start date
2018-12-19
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(K-diet, Control diet) : Control diet is defined based on the Westernized diet that Koreans routinely consume. Recruited individuals are randomly divided into two groups and then fed on the grou

Sponsors

Korea Food Research Institute
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) It recruits women who are in age of 20s to 60s, overweighted, do not have hypertension, diabetes and do not take hyperlipidemia drugs and female hormones. 2) Persons who can faithfully eat meals provided for about two months. 3) Those who voluntarily decide to participate and who have written their consent.

Exclusion criteria

Exclusion criteria: 1) Those who are unable to decide their own participation and who cannot sign consent forms 2) Those who are deemed unfit to participate in this study under the judgment of the researcher due to other serious illness or disability, etc. - a person who is allergic to certain food ingredients - Subject to drug abuse disorder or drug dependency disorder - Cognitive Disorders, Persons with Mental Disorders within the past six months - A person diagnosed with brachycardia, pyknocardia, arrhythmia or myocardial ischemia. - Thyroid disease patient - kidney and liver failure - A person whose LDL chlorsterol level exceeds 190 mg/dl on an empty stomach or who takes hyperlipidemia medication - A person whose Triglyceride level exceeds 300 mg/dl on an empty stomach or who takes hyperlipidemia medication - A person whose Glucose level exceeds 120 mg/dl on an empty stomach or who takes diabetes medication - A person with at least 150mmhg of systolic blood pressure and at least 100mmhg of diastolic blood pressure or who takes hypertension medication - a person on hormone medication - Patients with acute infection or who currently require taking antibiotics - smoker

Design outcomes

Primary

MeasureTime frame
Body Measurements Comparison

Secondary

MeasureTime frame
various biomarker, clinical marker, biochemical marker, epigenetic marker, molecular biology marker

Countries

Korea, Republic of

Contacts

Public ContactSangwoon Choi

CHA University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 12, 2026